$INCC - Summary of Trading - As At February 10 Close.

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
281
$INCC - Summary of Trading - As At February 10 Close.

Loading in .0002>.0013 range since last at .0001 x .0002:

.0002: 93M
.0003: 63M
.0004: 176M
.0005: 51M
.0006: 25M
.0007: 3M
.0008: 18M
.0009: 9M
.0010: 16M
.0011: 19M
.0012: 17M
.0013: 8M

Total: 498M to close on November 4.

November 7: 147M .0013 >.0025
November 8: 170M .0016 > .0033
November 9: 114M .0024 > .0011
November 10: 100M .0016 > .0008
November 11: 110M .0005 > .0010
November 14: 55M .0011 > .0015
November 15: 55M .0013 > .0021
November 16: 101M .0013 > .0025
November 17: 29M .0016 > .0023
November 18: 21M .0015 > .0019
November 21: 32M .0010 > .0017
November 22: 20M .0011 > .0017
November 23: 15M .0013 > .0017
November 25: 5M .0013 > .0017
November 28: 6M .0013 > .0016
November 29: 8M .0013 > .0016
November 30: 6M .0012 > .0015
December 1: 4M .0013 >.0015
December 2: 9M .0014 > .0016
December 5: 5M .0012 > .0016
December 6: 3M .0013 > .0015
December 7: 24M .0014 > .0016
December 8: 9M .0014 > .0017
December 9: 5M .0014 > .0016
December 12: 6M .0014 > .0016
December 13: 3M .0014 > .0016
December 14: 10M .0014 > .0015
December 15: 3M: .0013 > .0015
December 16: 7M .0013 > .0015
December 19: 5M .0013 > .0015
December 20: 3M .0013 > .0015
December 21: 5M .0013 > .0015
December 22: 5M .0013 > .0015
December 23: 12M .0013 > .0015
December 27: 93M .0014 > .0018
December 28: 42M .0015 > .0018
December 29: 48M .0015 > .0018
December 30: 42M .0014 > .0019
January 3: 68M .0013 > .0019
January 4: 9M .0014 > .0017
January 5: 68M .0012 > .0017
January 6: 11M .0012 > .0015
January 9: 23M: .0012 > .0017
January 10: 21M .0012 > .0015
January 11: 8M .0012 > .0015
January 12: 12M .0012 > .0014
January 13: 11M .0012 > .0014
January 17: 44M .0012 > .0014
January 18: 35M .0011 > .0014
January 19: 9M .0012>.0013
January 20: 21M .0010 > .0013
January 23: 40M .0008 > .0013
January 24: 13M .0008> .0010
January 25: 9M .0009 > .0010
January 26: 13M .0009 > .0011
January 27: 9M .0009 > .0011
January 30: 10M .0010 > .0012
January 31: 7M .0010 > .0012
February 1: 15M .0009 > .0011
February 2: 11M .0009 > .0010
February 3: 14M .0009 > .0010
February 6: 6M .0009 > .0010
February 7: 6M .0009 > .0010
February 8: 5M .0009 > .0010
February 9: 98M .0009 > .0014

February 10: 34M .0011 > .0014

Total since my alert at .0001 x .0002: 2.470B

Total loaded since hard bounce at .0010: 132M in 2 trading days.

Tersis Technologies, Inc. (TERS) Stock Research Links

TERS Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

MediaAlpha Set for Q3 2024 Financial Results Presentation

Updated Category News Views 77

MediaAlpha's Upcoming Financial Report Announcement MediaAlpha, Inc. (NYSE: MAX), based in Los Angeles, has exciting news for its investors and stakeholders. The company is gearing up to announce its financial results for the third quarter of 2024 on an upcoming Wednesday. This announcement will take place after the market closes, providing important insights into the...

Continue Reading
BigID Launches Innovative AI Data Access Control Solutions

Updated Category News Views 218

BigID Launches Innovative Solutions for AI Data Access Control Organizations are increasingly leveraging technology in ways that enhance workflows while prioritizing data security. BigID, a leader in the realm of data security and privacy, has introduced a groundbreaking method to prevent unauthorized access to sensitive information in Artificial Intelligence (AI)...

Continue Reading
Latigo Biotherapeutics Secures $150 Million to Innovate Pain Management

Updated Category News Views 442

Latigo Biotherapeutics Secures Major Funding for Pain Relief Advancement Latigo Biotherapeutics, a clinical-stage biotechnology firm dedicated to creating leading non-opioid pain management solutions, has officially closed a substantial $150 million in Series B financing. This funding round aims to push forward the development of their innovative Nav1.8 inhibitor...

Continue Reading
WisdomTree Moves Forward with UK Equity Income Shift

Updated Category News Views 119

WisdomTree's Strategic Shift in UK Equity Income In a significant move, the Directors of WisdomTree Issuer ICAV have officially announced plans to delist the WisdomTree UK Equity Income UCITS ETF. This decision comes as the company aims to merge its focus towards investing in UK Quality Dividend Growth strategies. The shares of this Sub-Fund will no longer be available...

Continue Reading
Avista Foundation's 2024 Grants: Supporting Community Initiatives

Updated Category News Views 384

Avista Foundation's Generous Grants in 2024 In its recent fourth-quarter granting cycle, the Avista Foundation has showcased its unwavering commitment to enhancing community welfare. The foundation distributed a remarkable total of $54,650 to 21 nonprofit organizations across various initiatives aimed at promoting environmental sustainability and enriching arts and...

Continue Reading